Scientist in front of whiteboard
Next-Generation Sequencing

Maximize insights with multimodal sequencing

Why choose QIAseq Multimodal technology?

Recent advances in NGS and bioinformatics have empowered researchers to efficiently interrogate DNA and RNA modifications in biological samples. However, current approaches require two separate workflows for DNA and RNA library preparation, each with inherent bias. Having different workflows increases costs and turnaround times, ultimately delaying the acquisition of actionable data. Limited sample availability can also impact your ability to achieve comprehensive genomic and transcriptomic insights.

One sample, one workflow and one day is all you need

Maximize the information you derive from a single total nucleic acid sample by simultaneously profiling DNA and RNA biomarkers in one consolidated workflow and just one day. With QIAseq Multimodal technology, you can interrogate various biomarkers in the same, single-day workflow from as little as 10 ng of sample.

Unlock DNA and RNA biomarker insights simultaneously
Explore how QIAseq Multimodal technology can save you valuable resources and time – discuss your project needs with us.
Dr. Vincent Funari
“QIAseq Multimodal Panels are a cutting-edge method that allowed us to simultaneously identify DNA variants and RNA fusions for comprehensive profiling of tumors.”

Dr. Vincent Funari, Vice President of Research and Development at NeoGenomics Laboratories

 

Go from sample to sequencing in a day
Need further information?
Explore performance data and more in our downloadable resources!
Target regions of interest with custom panels

Incorporate the benefits of QIAseq Multimodal technology and design your own panels. With our custom designs, you can target exonic regions of genes, hotspots or SNPs, intronic and promoter regions, known gene fusions based on characterized breakpoints and even discover novel fusions.

QIAseq Multimodal
Have a question about custom design?
Our specialists are ready to help you.

Comprehensive genomic profiling (CGP) is dramatically changing our understanding of various cancers, revealing an unprecedented level of detail. Multimodal sequencing can accelerate this rapidly evolving field of research.

Top 3 reasons to adopt a multimodal approach for CGP:

  1. Save time and resources: Consolidate separate workflows into a single-day, sample to sequencing workflow.
  2. Conserve precious samples: Simultaneously profile multiple DNA and RNA biomarkers, TMB and MSI from a single, low-input sample.
  3. Get deeper insights: Achieve a holistic view of various cancer biomarkers efficiently.
QIAseq Multimodal
Unlock insights into multiple cancers with just 10 ng total nucleic acid input

The QIAseq Pan-cancer Multimodal Panel enables simultaneous enrichment and profiling of 605 relevant DNA variant and RNA fusion biomarkers found across multiple cancers, as well as assessment of tumor mutational burden (TMB) and microsatellite instability (MSI), from a single sample input of 10 ng.

Ask our experts about comprehensive genomic profiling
Explore how QIAseq Multimodal technology can transfrom your cancer research.
What can you profile with the QIAseq Pan-cancer Multimodal Panel?

Explore the QIAseq Pan-cancer Multimodal Panel

Cover 523 DNA gene targets, 56 RNA fusion targets and 26 MSI loci.
Automate and accelerate your library prep
How can automating your NGS library prep benefit your lab?
All photos taken prior to COVID-19